ARCHIVES

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

This article is from The Cancer Letter archive.

Vol. 24 No. 48 | December 18, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

Big Get Bigger, Litton Primate Contract Renewed

September 19, 1975

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

ONF Invites Applications for Fatigue Research

April 19, 1996

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010